US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 77.870
  • -0.960-1.22%
Close Feb 14 16:00 ET
  • 78.300
  • +0.430+0.55%
Post 19:59 ET
345.79BMarket Cap24.53P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novo-Nordisk A/S Q4 2024 Earnings Date

Currency：USDFeb 5, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
11.18B
11.95B
+767.80M
Beat Est.
+14.69%
+22.56%
+6.86%
EPS
0.85
0.88
+0.03
Beat Est.
+17.33%
+21.65%
+3.68%
Analyst Rating
Buy

Feb 16, 2025

Novo-Nordisk A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 84.750B--
--2025/Q1-- / 81.667B--
Feb 5, 20252024/Q485.683B / 80.179B--
Nov 6, 20242024/Q371.311B / 71.869B--
Aug 7, 20242024/Q268.060B / 68.563B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 84.750B--
--2025/Q1-- / 81.667B--
Feb 5, 20252024/Q485.683B / 80.179B
Novo Nordisk Q4 2023 earnings conference call
Jan 31 06:00
Replay
Nov 6, 20242024/Q371.311B / 71.869B--
Aug 7, 20242024/Q268.060B / 68.563B--

Unlock Free Earnings Estimates

Novo-Nordisk A/S Earnings Reports

  • 6-K: Financial Report for the Period 1 January 2024 to 31 December 2024

    Feb 5 07:20 ET

  • 20-F: FY2024 Annual Report

    Feb 5 07:09 ET

  • 6-K: Financial Report for the Period 1 January 2024 to 30 September 2024

    Nov 6, 2024 06:37 ET

  • 6-K: Financial Report for the Period 1 January 2024 to 30 June 2024

    Aug 7, 2024 06:56 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 16, 2025

    Buy

    • Buy

      66.67%

    • Hold

      16.67%

    • Sell

      16.67%

    Price Target

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday-2.11%